From: Stock Gumshoe<[email protected]>
Subject: What's the Motley Fool touting as their largest position?
Preheader: Checking out the latest Stock Advisor teaser
Reply: [email protected]
You're receiving this email newsletter because you, or someone
using [email protected], signed up for the Stock Gumshoe Daily Update
 
Please unsubscribe if you don't want Stock Gumshoe emails
(this will not cancel membership, just stop emails). 
DAILY UPDATE
May 21, 2018
email formatted funny? Web version
Dear Valued Reader,

The Motley Fool folks are out promoting their number one idea for 2018 now, what they call the "$1 Million Bet for 2018" ... you probably don't need your own Thinkolator to come up with the answer to this one, the universe of possible matches is very small, but we can't resist a quick look at a "million dollar stock" ... so just click below to...

Master trader Jim Fink trades the market for extra cash… and averages $185 per day. $185.06 to be exact. That adds up to $67,548 per year, and if you follow his strategy, you can do the same thing yourself. Why not? All it takes is nine minutes a week. And you don’t have to invest a dime up front.

Go here to see if this $67,548-a-year system is for you.
Advertisement

Miss anything?

We started things off last week with a look into a company that Jason Stutman is pitching as "The Netflix of Medicine" -- catchy phrase, that, so what's the stock  he's touting?  Answers here.

From there we moved on to another in a long string of misleading ads that give the impression we can just "sign up" to get free money -- this one isn't as bad as some, but it still generated a lot of questions. Nilus Mattive is promoting his new Rich Life newsletter by dangling the notion that you can get "Liberty Vouchers" that will provide you with "Relentless Income."  Is it the same general idea as "Trump Bonus Checks" or "Freedom Checks" that have been touted by others? Click here to see that story and we'll share what we learned.

Then Doc Gumshoe came back for another of his missives -- and it led us to wonder, are you better at chopping onions or folding laundry?  It's OK, you don't have to confess... but I thought Michael had a fascinating story to tell, and you can see that here.

Then, as if the "Netflix of Medicine" weren't tantalizing enough, another pundit was out promoting an investment in "Amazon 2.0" -- it has to do with Wal-Mart and a stock that he implies you can buy before it's massive IPO... our story is here.

Lots and lots and lots of questions are hitting now about the latest "Marijuana Takeover" stock -- Zackary Scheidt over at Agora is saying that he thinks Anheuser-Busch will soon be making an offer for his favorite "triple play" marijuana company, following in the footsteps of Constellation's investment in Canopy Growth last year.  So what's the stock?  Is it intersting?  I dug into it in this week's Friday File missive for the Irregulars, which our favorite people can read right here.

And finally, a bonus thread at the end of the week: 

Did your teacher every sit you down and say, "there's no such thing as a dumb question?"  We know that we should ask questions, that's how we learn... but sometimes it's just too embarrassing to ask a question that we think makes us look stupid.  So today, in a bonus Q&A, I'm opening up the floor to any question you want to ask me -- stupid or otherwise.  What do you want to know about investing?  About Stock Gumshoe?  Let your curiosity take wing, and we'll try to help.  I've answered a bunch of them so far, and others have chimed in as well, and I'm trying to catch up and get to them all... Just click below to...

IRREGULARS CORNER

Latest Real Money Portfolio

Disclaimer: Nothing in this email or in the linked articles should be considered to be individual investment advice -- we can't tell you what you should do with your money, we can just share our opinions and perspective. Our authors try to use reliable information sources but also make mistakes of both fact and judgement on occasion, so all assertions should be checked and confirmed. You should speak with your financial advisor and understand everything fully before committing money to any investment.

Most issues of this email newsletter include advertising, and it should not be assumed that the presence of an advertisement means that the product or service advertised is endorsed by Stock Gumshoe or the author. For full disclaimers, disclosure information, and privacy policies please see the prominent links at the bottom of each page at StockGumshoe.com.

If you wish to unsubscribe to these mailings, there are links at both the bottom and top of this email that you can use to do so permanently and safely, we have no wish to email people who don't want to receive these messages. Please note that unsubscribing using the link below applies only to receiving emails, if you are a member of the Stock Gumshoe Irregulars that membership will not automatically change or be canceled. Please contact us if you need to change a paid membership.
Unsubscribe
Stock Gumshoe, 351 Pleasant St., Suite B #205, Northampton, MA 01060